Hideki Tsujimura

2.2k citations

44 papers · 1.4k indexed · h-index 13

Impact in

Immunology top 2%
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
- Immune Cell Function and Interaction
- Immune Response and Inflammation
- interferon and immune responses
- Immune cells in cancer
Oncology top 10%
- Cytokine Signaling Pathways and Interactions

Papers in ⓘ

Hematology 13
- Multiple Myeloma Research and Treatments 7
- Acute Myeloid Leukemia Research 4
Pathology and Forensic Medicine 15
- Lymphoma Diagnosis and Treatment 14

Co-authors: Keiko Ozato (8 shared papers)Tomohiko Tamura (7 shared papers)Hee Jeong Kong (3 shared papers)Caetano Reis e Sousa (2 shared papers)Alan Sher (2 shared papers)Júlio Aliberti (2 shared papers)Kunihiro Yamaoka (1 shared paper)Harinder Singh (1 shared paper)
Journals: Blood (8 papers)The Journal of Immunology (4 papers)Journal of Hepatology (2 papers)Annals of Oncology (2 papers)European Journal of Gastroenterology & Hepatology (1 paper)
Partner nations: Japan United States United Kingdom

In The Last Decade

Hideki Tsujimura

40 papers receiving 1.4k citations

Peers

Countries citing papers authored by Hideki Tsujimura

Since Specialization

Citations

This map shows the geographic impact of Hideki Tsujimura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideki Tsujimura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideki Tsujimura more than expected).

Fields of papers citing papers by Hideki Tsujimura

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideki Tsujimura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideki Tsujimura. The network helps show where Hideki Tsujimura may publish in the future.

Co-authors

The 25 scholars most cited alongside Hideki Tsujimura, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hideki Tsujimura Line = papers co-authored together Hideki Tsujimura links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	IFN Regulatory Factor-4 and -8 Govern Dendritic Cell Subset Development and Their Functional Diversity The Journal of Immunology ·Tomohiko Tamura, Prafullakumar Tailor, Kunihiro Yamaoka, Hee Jeong Kong, Hideki Tsujimura, John J. O’Shea, Harinder Singh, Keiko Ozato	2005	341
2	Essential role for ICSBP in the in vivo development of murine CD8α+ dendritic cells Blood ·Júlio Aliberti, Oliver Schulz, Daniel J. Pennington, Hideki Tsujimura, Caetano Reis e Sousa, Keiko Ozato, Alan Sher	2002	251
3	Cutting Edge: IFN Consensus Sequence Binding Protein/IFN Regulatory Factor 8 Drives the Development of Type I IFN-Producing Plasmacytoid Dendritic Cells The Journal of Immunology ·Hideki Tsujimura, Tomohiko Tamura, Keiko Ozato	2003	195
4	Toll-Like Receptor Signaling and Regulation of Cytokine Gene Expression in the Immune System BioTechniques ·Keiko Ozato, Hideki Tsujimura, Tomohiko Tamura	2002	155
5	Toll-Like Receptor 9 Signaling Activates NF-κB through IFN Regulatory Factor-8/IFN Consensus Sequence Binding Protein in Dendritic Cells The Journal of Immunology ·Hideki Tsujimura, Tomohiko Tamura, Hee Jeong Kong, Akira Nishiyama, Ken J. Ishii, Dennis M. Klinman, Keiko Ozato	2004	124
6	ICSBP/IRF-8 retrovirus transduction rescues dendritic cell development in vitro Blood ·Hideki Tsujimura, Tomohiko Tamura, Céline Gongora, Júlio Aliberti, Caetano Reis e Sousa, Alan Sher, Keiko Ozato	2003	96
7	IFN Consensus Sequence Binding Protein/IFN Regulatory Factor-8 Guides Bone Marrow Progenitor Cells Toward the Macrophage Lineage The Journal of Immunology ·Hideki Tsujimura, Tokiko Nagamura‐Inoue, Tomohiko Tamura, Keiko Ozato	2002	74
8	ICSBP/IRF-8 inhibits mitogenic activity of p210 Bcr/Abl in differentiating myeloid progenitor cells Blood ·Tomohiko Tamura, Hee Jeong Kong, Chainarong Tunyaplin, Hideki Tsujimura, Kathryn Calame, Keiko Ozato	2003	53
9	Fatal chronic active Epstein–Barr virus infection mimicking autoimmune hepatitis European Journal of Gastroenterology & Hepatology ·Tetsuhiro Chiba, Shigemasa Goto, Osamu Yokosuka, Fumio Imazeki, Masamichi Tanaka, Kenichi Fukai, Yōko Takahashi, Hideki Tsujimura, Hiromitsu Saisho	2004	30
10	Loss of CD38 Expression in Relapsed Refractory Multiple Myeloma Clinical Lymphoma Myeloma & Leukemia ·Mikiko Ise, Keiko Matsubayashi, Hideki Tsujimura, Kyoya Kumagai	2016	18
11	Successful treatment of histiocytic sarcoma with induction chemotherapy consisting of dose-escalated CHOP plus etoposide and upfront consolidation auto-transplantation International Journal of Hematology ·Hideki Tsujimura, Toshiko Miyaki, Shuhei Yamada, Takeaki Sugawara, Mikiko Ise, Shintaro Iwata, Tsukasa Yonemoto, Dai Ikebe, Makiko Itami, Kyoya Kumagai	2014	16
12	Expression of activation-induced cytidine deaminase is associated with a poor prognosis of diffuse large B cell lymphoma patients treated with CHOP-based chemotherapy Journal of Cancer Research and Clinical Oncology ·Kiyoko Kawamura, Akihiko Wada, Ji‐Yang Wang, Quanhai Li, Akihiro Ishii, Hideki Tsujimura, Toshiyuki Takagi, Makiko Itami, Yuji Tada, Koichiro Tatsumi, Hideaki Shimada, Kenzo Hiroshima, Masatoshi Tagawa	2015	15
13	Significance of parathyroid hormone-related protein as a factor stimulating bone resorption and causing hypercalcemia in myeloma American Journal of Hematology ·Hideki Tsujimura, Fumitaka Nagamura, Tohru Iseki, Shoichiro Kanazawa, Hiromitsu Saisho	1998	12
14	Therapy‐related leukemia following chemoradiotherapy for esophageal cancer European Journal Of Haematology ·Naoya Mimura, Hideki Tsujimura, Mikiko Ise, Chikara Sakai, Toshiyuki Takagi, Matsuo Nagata, Kyoya Kumagai	2010	8
15	Involvement of the Appendix in a Relapsed Case of Primary Nasal NK/T-Cell Lymphoma Leukemia & lymphoma ·Hideki Tsujimura, Toshiyuki Takagi, Jun‐ichi Tamaru, Chikara Sakai	2000	7
16	Maxillary Swelling as the First Evidence of Multiple Myeloma Case Reports in Dentistry ·Atsushi Kasamatsu, Yasushi Kimura, Hideki Tsujimura, Harusachi Kanazawa, Nao Koide, Isao Miyamoto, Yosuke Endo‐Sakamoto, Masashi Shiiba, Hideki Tanzawa, Katsuhiro Uzawa	2015	6
17	521 PROSPECTIVE STUDY OF HEPATITIS B VIRUS REACTIVATION IN HBSAG-NEGATIVE PATIENTS AFTER CHEMOTHERAPY WITH RITUXIMAB: HBV-DNA MONITORING AND ENTECAVIR PROPHYLAXIS Journal of Hepatology ·H. Kojima, Hideki Tsujimura, T. Sugawara, Naoya Mimura, Mikiko Ise, Chiho Sakai, Satoshi Yamada, Tomokatsu Miyaki, Kotaro Kumagai	2012	6
18	Mediastinal Follicular Lymphoma Diagnosed with Multidirectional Analysis Using Tissue Samples Obtained by EBUS-TBNA Internal Medicine ·Masahiro Inoue, Takahiro Nakajima, Hideki Tsujimura, Makiko Itami, Yuichi Sakairi, Hideki Kimura, Toshihiko Iizasa	2010	5
19	HLA genotyping in Japanese patients with multiple myeloma receiving bortezomib: An exploratory biomarker study of JCOG1105 (JCOG1105A1) Cancer Science ·Masaki Ri, Shinsuke Iida, Dai Maruyama, Aya Sakabe, Ryo Kamei, T. NAKASHIMA, Masahiro Tohkin, Satoshi Osaga, Kensei Tobinai, Noriko Fukuhara, Kana Miyazaki, Norifumi Tsukamoto, Hideki Tsujimura, Makoto Yoshimitsu, Ken‐ichi Miyamoto, Kunihiro Tsukasaki, Hirokazu Nagai	2021	3
20	Successful treatment with biweekly CHOP for bone marrow relapse of blastic plasmacytoid dendritic cell neoplasm. PubMed ·Keiko Ono, Mikiko Ise, Dai Ikebe, Akiyasu Sato, Xiaofei Wang, Takeaki Sugawara, Hideki Tsujimura, Makiko Itami, Kyoya Kumagai	2017	3

About Hideki Tsujimura

Hideki Tsujimura is a scholar working on Hematology, Pathology and Forensic Medicine, Oncology, Genetics and Hepatology, having authored 44 papers that have together received 1.4k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (14 papers), Multiple Myeloma Research and Treatments (7 papers), Chronic Lymphocytic Leukemia Research (6 papers), Immune Response and Inflammation (6 papers), Immunotherapy and Immune Responses (5 papers), CNS Lymphoma Diagnosis and Treatment (5 papers), Acute Myeloid Leukemia Research (4 papers) and Viral-associated cancers and disorders (4 papers). The work is most often cited by research in Immunology (1.1k citations), Oncology (322 citations), Hematology (117 citations), Cancer Research (108 citations) and Immunology and Allergy (32 citations). Hideki Tsujimura has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Keiko Ozato, Tomohiko Tamura, Hee Jeong Kong, Caetano Reis e Sousa, Alan Sher, Júlio Aliberti, Kunihiro Yamaoka, Harinder Singh, John J. O’Shea and Prafullakumar Tailor. Their work appears in journals such as Blood, The Journal of Immunology, Journal of Hepatology, Annals of Oncology and European Journal of Gastroenterology & Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact